Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging.

CONCLUSION: The prediction model based on gadoxetic acid-enhanced MRI features in addition to the known predictors including tumor size and number can be used to estimate the risk of TACE refractoriness in patients with intermediate-stage HCC. PMID: 33197329 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33197329?dopt=Abstract

Source: Acta Radiologica - November 16, 2020 Category: Radiology Authors: Byun J, Kim SY, Kim JH, Kim MJ, Yoo C, Shim JH, Lee SS Tags: Acta Radiol Source Type: research